Ixekizumab-Associated Generalized Vitiligo and Pruritus in a Psoriatic Patient
Authors:
Open Access
- 1 September 2024
- journal article
- letter
- Published by Medknow in Indian Journal of Dermatology
- Vol. 69 (5) , 416-418
Abstract
No abstract availableKeywords
This publication has 5 references indexed in Scilit:
- Anti-IL-17A antibody-associated de novo vitiligo: Case report and review of literatureFrontiers in Immunology, 2023
- Generalized vitiligo in a psoriatic patient treated with ixekizumabDermatologic Therapy, 2022
- Neutrophils promote CXCR3-dependent itch in the development of atopic dermatitiseLife, 2019
- Three cases of facial erythema with dryness and pruritus in psoriasis patients during treatment with IL‐17 inhibitorsJournal of the European Academy of Dermatology and Venereology, 2017
- Type I interferon signature in the initiation of the immune response in vitiligoPigment Cell & Melanoma Research, 2014